Direct Oral Anticoagulant Monitoring Personalized Dosing Strategies 2025
The Challenge of Measuring Novel Anticoagulants Direct Oral Anticoagulants (DOACs), such as apixaban and rivaroxaban, have largely replaced older drugs for managing conditions like atrial fibrillation and venous thromboembolism. While their predictable pharmacology often eliminates the need for routine monitoring, critical scenarios—such as emergency surgery, severe bleeding, or assessing...
0 Comments 0 Shares 46 Views 0 Reviews
MakeMyFriends https://makemyfriends.com